Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation

Autor: van Zuijlen, A.D., Berger, Dr.SP., Bemelman, F.J., van der Heijden, J.W., van de Wetering, J., de Vries, A.P.J., Wetzels, J.F.M., van Wijk, J.A.E., Bouts, A.H.M., Dorresteijn, E.M., Gracchi, V., Horuz-Engels, F.A.P.T., Keijzer-Veen, M.G., van Rooij, R.W.G., van de Kar, N.C.A.J., van den Heuvel, L.P., Duineveld, Caroline, Bouwmeester, Romy N., Wijnsma, Kioa L., Berger, S.P., van den Heuvel, L.P.W.J., van de Kar, Nicole C.A.J., Wetzels, Jack F.M.

Publikováno v: In Kidney International Reports April 2023 8(4):715-726

Early eculizumab withdrawal in patients with atypical hemolytic uremic syndrome in native kidneys is safe and cost-effective

Autor: Bouwmeester, R.N., Duineveld, C., Wijnsma, K.L., Bemelman, F.J., Heijden, J.W. van der, Wijk, J.A.E. van, Bouts, A.H.M., Wetering, J. van de, Dorresteijn, E., Berger, S.P., Gracchi, V., Zuilen, A.D. van, Keijzer-Veen, M.G., Vries, A.P.J. de, Rooij, R.W.G. van, Engels, F.A.P.T., Altena, W., Wildt, R. de, Kempen, E. van, Adang, E.M., Avest, M. ter, Heine, R. ter, Volokhina, E.B., Heuvel, L.P.W.J. van den, Wetzels, J.F.M., Kar, N.C.A.J. van de

Publikováno v: Bouwmeester, R N, Duineveld, C, Wijnsma, K L, Bemelman, F J, van der Heijden, J W, van Wijk, J A E, Bouts, A H M, van de Wetering, J, Dorresteijn, E, Berger, S P, Gracchi, V, van Zuilen, A D, Keijzer-Veen, M G, de Vries, A P J, van Rooij, R W G, Engels, F A P T, Altena, W, de Wildt, R, van Kempen, E, Adang, E M, ter Avest, M, ter Heine, R, Volokhina, E B, van den Heuvel, L P W J, Wetzels, J F M & van de Kar, N C A J 2022, ' Early Eculizumab Withdrawal in Patients With Atypical Hemolytic Uremic Syndrome in Native Kidneys Is Safe and Cost-Effective : Results of the CUREiHUS Study ', Kidney International Reports, vol. 8, no. 1, pp. 91-102 . https://doi.org/10.1016/j.ekir.2022.10.013
Kidney International Reports, 8(1), 91-102. Elsevier Inc.
Kidney International Reports, 8, 1, pp. 91-102
Kidney International Reports, 8(1), 91-102. Elsevier Science
Kidney International Reports, 8(1), 91-102. ELSEVIER SCIENCE INC
Kidney International Reports, 8, 91-102
Kidney International Reports. Elsevier Inc.

Introduction: The introduction of eculizumab has improved the outcome in patients with atypical hemo-lytic uremic syndrome (aHUS). The optimal treatment strategy is debated. Here, we report the results of the CUREiHUS study, a 4-year prospective, obs

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7d699e40d5937c24775971a41a47d3
https://hdl.handle.net/1887/3563249

Uncovering risk factors for kidney injury in children with a solitary functioning kidney

Autor: Groen in ‘t Woud, Sander, Roeleveld, Nel, Westland, Rik, Renkema, Kirsten Y., Steffens, Martijn G., Gracchi, Valentina, Lilien, Marc R., van Wijk, Joanna A.E., Feitz, Wout F.J., Schreuder, Michiel F., van der Zanden, Loes F.M., Beeren, M.C.G., Blokland-Loggers, H.E., Breukels, M., van den Broek, L.M., del Canho, R., Creemers, D., van Dael, C.M.L., van der Deure, H., Dings-Lammertink, A., Dorrepaal, C., Dorresteijn, E., Feitz, W.F.J., Gracchi, V., Groen in ‘t Woud, S., Harnisch, E., Jacobs, M.J., Jira, P.E., Keijzer-Veen, M.G., Kloosterman, F.J., Knots, E., Konijnenberg, A.Y., Koppejan-Stapel, M., van der Kuur, E.C., van Ledden-Klok, M.J., Leunissen, R.W.J., Lilien, M.R., Jansen, C. Meine, de Moor, R., Nijhuis, I.J.M., Pierik, L.J.W.M., Pijning, A., de Pont, S.M.H.B., Renkema, K.Y., Rijlaarsdam, R., Roeleveld, N., van Rooij, R.W.G., Schreuder, M.F., Semmekrot, B., Steffens, M.G., Tanja, A.L., Westland, R., van Wijk, J.A.E., Wijnands - van den Berg, E., van der Zanden, L.F.M., Zegers, B.

Publikováno v: Kidney International; January 2023, Vol. 103 Issue: 1 p156-165, 10p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.